The novel spectrometry market size has grown strongly in recent years. It will grow from $4.76 billion in 2025 to $5.15 billion in 2026 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to pharmaceutical quality control expansion, growth in environmental monitoring regulations, adoption of mass spectrometry in forensic science, rising food safety testing requirements, academic and research laboratory investments.
The novel spectrometry market size is expected to see strong growth in the next few years. It will grow to $6.97 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to automation of analytical laboratories, demand for portable spectrometry devices, growth of personalized medicine research, expansion of industrial process analytics, increased funding for advanced material science. Major trends in the forecast period include AI-enhanced spectral data interpretation, smart factory integration of spectrometry systems, connected and remote spectrometry platforms, cloud-based spectral data management, precision medicine-driven analytical spectrometry.
The increasing demand for personalized medicine is increasingly supporting the expansion of the novel spectrometry market going forward. Personalized medicine is a healthcare approach that customizes treatments based on individual genetic, environmental, and lifestyle factors. Demand for personalized medicine is rising due to advances in genomics, which enable more precise therapies and improved patient outcomes through targeted interventions. Novel spectrometry supports personalized medicine by enabling accurate biomarker analysis and the development of tailored treatment plans, enhancing therapeutic effectiveness. For example, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the US Food and Drug Administration approved 16 new personalized treatments for rare diseases in 2023, compared to six approvals in 2022. Consequently, rising demand for personalized medicine is strengthening the novel spectrometry market.
Leading companies operating in the novel spectrometry market are developing technologically advanced solutions such as next-generation triple-quadrupole mass spectrometers to enhance sensitivity, accuracy, and analytical performance. Advanced triple-quadrupole mass spectrometers are optimized for both quantitative and qualitative analysis of complex samples. For example, in June 2023, Bruker Corporation, a US-based scientific instrument manufacturer, introduced the EVOQ DART-TQ+, a triple-quadrupole mass spectrometer designed for chromatography-free analysis. The system integrates direct analysis in real time ionization, enabling rapid and cost-effective workflows for food, forensic, industrial, and environmental applications.
In June 2023, Thermo Fisher Scientific, a US-based life science and clinical research company, acquired MarqMetrix, Inc. for an undisclosed amount. Through this acquisition, Thermo Fisher Scientific aimed to strategically strengthen its Raman spectroscopy portfolio by incorporating MarqMetrix’s complementary and innovative in-line Process Analytical Technology solutions. MarqMetrix is a US-based company providing advanced process Raman spectrometry technologies.
Major companies operating in the novel spectrometry market are Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Teledyne Photon Instruments, PerkinElmer Inc., LECO Corporation, Endress+Hauser Group, Shimadzu Corporation, Waters Corporation, Bruker Corporation, Horiba Ltd., FLIR Systems Inc., Sciex, JEOL Ltd., Oxford Instruments plc, Rigaku Corporation, Peak Scientific Instruments Ltd., Nanalysis Corp., Scion Instruments, Hiden Analytical Ltd., Labman Automation Ltd., Advion Inc., Exciton Inc., SRI Instruments.
North America was the largest region in the novel spectrometry market in 2025. The regions covered in the novel spectrometry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the novel spectrometry market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the novel spectrometry market by increasing costs for imported precision components, sensors, and advanced optical systems, impacting manufacturing timelines and pricing strategies. High-end spectrometers such as mass spectrometers, NMR spectrometers, and X-ray fluorescence systems are most affected, particularly in regions dependent on cross-border trade like Asia-Pacific and Europe. Small and mid-sized manufacturers face margin pressure, while large players absorb costs through localized sourcing. On the positive side, tariffs are encouraging domestic manufacturing, regional supply chain diversification, and innovation in cost-efficient spectrometry solutions.
The novel spectrometry market research report is one of a series of new reports that provides novel spectrometry market statistics, including novel spectrometry industry global market size, regional shares, competitors with a novel spectrometry market share, detailed novel spectrometry market segments, market trends and opportunities, and any further data you may need to thrive in the novel spectrometry industry. This novel spectrometry market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Novel spectrometry refers to advanced or innovative spectrometry technologies that improve the analysis of how light interacts with matter, enhancing accuracy and capability in measuring substance properties.
The main spectrometer types in novel spectrometry include atomic absorption spectrometers, mass spectrometers, near-infrared spectrometers, nuclear magnetic resonance spectrometers, Raman spectrometers, and X-ray fluorescence spectrometers. Atomic absorption spectrometers are analytical instruments used to determine elemental concentrations by measuring the absorption of light by vaporized samples. These spectrometers are suitable for organizations of all sizes, including small, mid-sized, and large enterprises, and serve end users in agriculture and pesticide testing, environmental analysis, food biotechnology, forensic analysis, pharmaceutical testing, and others.
The novel spectrometry market includes revenues earned by entities by providing services such as environmental monitoring, trace analysis, high-resolution analysis, and biological and medical diagnostics. The market value includes the value of related goods sold by the service provider or included within the service offering. The novel spectrometry market also consists of sales of portable spectrometers, advanced spectrometers, multimodal spectroscopy systems, and enhanced data processing software. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The novel spectrometry market size is expected to see strong growth in the next few years. It will grow to $6.97 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to automation of analytical laboratories, demand for portable spectrometry devices, growth of personalized medicine research, expansion of industrial process analytics, increased funding for advanced material science. Major trends in the forecast period include AI-enhanced spectral data interpretation, smart factory integration of spectrometry systems, connected and remote spectrometry platforms, cloud-based spectral data management, precision medicine-driven analytical spectrometry.
The increasing demand for personalized medicine is increasingly supporting the expansion of the novel spectrometry market going forward. Personalized medicine is a healthcare approach that customizes treatments based on individual genetic, environmental, and lifestyle factors. Demand for personalized medicine is rising due to advances in genomics, which enable more precise therapies and improved patient outcomes through targeted interventions. Novel spectrometry supports personalized medicine by enabling accurate biomarker analysis and the development of tailored treatment plans, enhancing therapeutic effectiveness. For example, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the US Food and Drug Administration approved 16 new personalized treatments for rare diseases in 2023, compared to six approvals in 2022. Consequently, rising demand for personalized medicine is strengthening the novel spectrometry market.
Leading companies operating in the novel spectrometry market are developing technologically advanced solutions such as next-generation triple-quadrupole mass spectrometers to enhance sensitivity, accuracy, and analytical performance. Advanced triple-quadrupole mass spectrometers are optimized for both quantitative and qualitative analysis of complex samples. For example, in June 2023, Bruker Corporation, a US-based scientific instrument manufacturer, introduced the EVOQ DART-TQ+, a triple-quadrupole mass spectrometer designed for chromatography-free analysis. The system integrates direct analysis in real time ionization, enabling rapid and cost-effective workflows for food, forensic, industrial, and environmental applications.
In June 2023, Thermo Fisher Scientific, a US-based life science and clinical research company, acquired MarqMetrix, Inc. for an undisclosed amount. Through this acquisition, Thermo Fisher Scientific aimed to strategically strengthen its Raman spectroscopy portfolio by incorporating MarqMetrix’s complementary and innovative in-line Process Analytical Technology solutions. MarqMetrix is a US-based company providing advanced process Raman spectrometry technologies.
Major companies operating in the novel spectrometry market are Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Teledyne Photon Instruments, PerkinElmer Inc., LECO Corporation, Endress+Hauser Group, Shimadzu Corporation, Waters Corporation, Bruker Corporation, Horiba Ltd., FLIR Systems Inc., Sciex, JEOL Ltd., Oxford Instruments plc, Rigaku Corporation, Peak Scientific Instruments Ltd., Nanalysis Corp., Scion Instruments, Hiden Analytical Ltd., Labman Automation Ltd., Advion Inc., Exciton Inc., SRI Instruments.
North America was the largest region in the novel spectrometry market in 2025. The regions covered in the novel spectrometry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the novel spectrometry market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the novel spectrometry market by increasing costs for imported precision components, sensors, and advanced optical systems, impacting manufacturing timelines and pricing strategies. High-end spectrometers such as mass spectrometers, NMR spectrometers, and X-ray fluorescence systems are most affected, particularly in regions dependent on cross-border trade like Asia-Pacific and Europe. Small and mid-sized manufacturers face margin pressure, while large players absorb costs through localized sourcing. On the positive side, tariffs are encouraging domestic manufacturing, regional supply chain diversification, and innovation in cost-efficient spectrometry solutions.
The novel spectrometry market research report is one of a series of new reports that provides novel spectrometry market statistics, including novel spectrometry industry global market size, regional shares, competitors with a novel spectrometry market share, detailed novel spectrometry market segments, market trends and opportunities, and any further data you may need to thrive in the novel spectrometry industry. This novel spectrometry market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Novel spectrometry refers to advanced or innovative spectrometry technologies that improve the analysis of how light interacts with matter, enhancing accuracy and capability in measuring substance properties.
The main spectrometer types in novel spectrometry include atomic absorption spectrometers, mass spectrometers, near-infrared spectrometers, nuclear magnetic resonance spectrometers, Raman spectrometers, and X-ray fluorescence spectrometers. Atomic absorption spectrometers are analytical instruments used to determine elemental concentrations by measuring the absorption of light by vaporized samples. These spectrometers are suitable for organizations of all sizes, including small, mid-sized, and large enterprises, and serve end users in agriculture and pesticide testing, environmental analysis, food biotechnology, forensic analysis, pharmaceutical testing, and others.
The novel spectrometry market includes revenues earned by entities by providing services such as environmental monitoring, trace analysis, high-resolution analysis, and biological and medical diagnostics. The market value includes the value of related goods sold by the service provider or included within the service offering. The novel spectrometry market also consists of sales of portable spectrometers, advanced spectrometers, multimodal spectroscopy systems, and enhanced data processing software. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Novel spectrometry Market Characteristics
3. Novel spectrometry Market Supply Chain Analysis
4. Global Novel spectrometry Market Trends and Strategies
5. Novel spectrometry Market Analysis of End Use Industries
7. Global Novel spectrometry Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Novel spectrometry Total Addressable Market (TAM) Analysis for the Market
9. Novel spectrometry Market Segmentation
10. Novel spectrometry Market Regional and Country Analysis
11. Asia-Pacific Novel spectrometry Market
12. China Novel spectrometry Market
13. India Novel spectrometry Market
14. Japan Novel spectrometry Market
15. Australia Novel spectrometry Market
16. Indonesia Novel spectrometry Market
17. South Korea Novel spectrometry Market
18. Taiwan Novel spectrometry Market
19. South East Asia Novel spectrometry Market
20. Western Europe Novel spectrometry Market
21. UK Novel spectrometry Market
22. Germany Novel spectrometry Market
23. France Novel spectrometry Market
24. Italy Novel spectrometry Market
25. Spain Novel spectrometry Market
26. Eastern Europe Novel spectrometry Market
27. Russia Novel spectrometry Market
28. North America Novel spectrometry Market
29. USA Novel spectrometry Market
30. Canada Novel spectrometry Market
31. South America Novel spectrometry Market
32. Brazil Novel spectrometry Market
33. Middle East Novel spectrometry Market
34. Africa Novel spectrometry Market
36. Novel spectrometry Market Competitive Landscape and Company Profiles
37. Novel spectrometry Market Other Major and Innovative Companies
40. Novel spectrometry Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Novel spectrometry Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses novel spectrometry market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for novel spectrometry? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The novel spectrometry market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type Of Spectrometers: Atomic Absorption Spectrometer; Mass Spectrometer; Near Infrared Spectrometer; Nuclear Magnetic Resonance Spectrometer; Raman Spectrometer; X-Ray Fluorescence Spectrometer2) By Company Size: Small; Mid-Sized; Large
3) By End-User: Agriculture Or Pesticide Testing; Environmental Analysis; Food Biotechnology; Forensic Analysis; Pharmaceutical Analysis; Other End Users
Subsegments:
1) By Atomic Absorption Spectrometer: Flame Atomic Absorption Spectrometers (FAAS); Graphite Furnace Atomic Absorption Spectrometers (GFAAS); Hydride Generation Atomic Absorption Spectrometers2) By Mass Spectrometer: Quadrupole Mass Spectrometers; Time-Of-Flight Mass Spectrometers (TOF-MS); Ion Trap Mass Spectrometers; Orbitrap Mass Spectrometers
3) By Near Infrared Spectrometer: Dispersive Near Infrared Spectrometers; Fourier Transform Near Infrared Spectrometers (FT-NIR); NIR Spectrometers for Industrial Applications
4) By Nuclear Magnetic Resonance Spectrometer: High-Field NMR Spectrometers; Low-Field NMR Spectrometers; Portable NMR Spectrometers
5) By Raman Spectrometer: Dispersive Raman Spectrometers; FT-Raman Spectrometers; Portable Raman Spectrometers
6) By X-Ray Fluorescence Spectrometer: Energy Dispersive X-Ray Fluorescence (EDXRF) Spectrometers; Wavelength Dispersive X-Ray Fluorescence (WDXRF) Spectrometers; Portable X-Ray Fluorescence Spectrometers
Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; Agilent Technologies Inc.; Teledyne Photon Instruments; PerkinElmer Inc.; LECO Corporation; Endress+Hauser Group; Shimadzu Corporation; Waters Corporation; Bruker Corporation; Horiba Ltd.; FLIR Systems Inc.; Sciex; JEOL Ltd.; Oxford Instruments plc; Rigaku Corporation; Peak Scientific Instruments Ltd.; Nanalysis Corp.; Scion Instruments; Hiden Analytical Ltd.; Labman Automation Ltd.; Advion Inc.; Exciton Inc.; SRI Instruments
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Novel spectrometry market report include:- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Agilent Technologies Inc.
- Teledyne Photon Instruments
- PerkinElmer Inc.
- LECO Corporation
- Endress+Hauser Group
- Shimadzu Corporation
- Waters Corporation
- Bruker Corporation
- Horiba Ltd.
- FLIR Systems Inc.
- Sciex
- JEOL Ltd.
- Oxford Instruments plc
- Rigaku Corporation
- Peak Scientific Instruments Ltd.
- Nanalysis Corp.
- Scion Instruments
- Hiden Analytical Ltd.
- Labman Automation Ltd.
- Advion Inc.
- Exciton Inc.
- SRI Instruments
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 5.15 Billion |
| Forecasted Market Value ( USD | $ 6.97 Billion |
| Compound Annual Growth Rate | 7.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |
